Novavax (NVAX)
Novavax Key Statistics
Pro Data ExportCurrent Valuation
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 18.44% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | -158.0% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 3.372 |
| Debt to Equity Ratio | 0.0075 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -9.19% |
| Year to Date Stock Returns | -1.98% |
| 1 Year Stock Returns | -47.22% |
| 3 Year Stock Returns | -32.88% |
| 52 Week High | 2.45 |
| 52 Week Low | 1.12 |
Income Statement
| Revenues TTM | 18.50M |
| Revenue Per Share TTM | 0.1521 |
| Revenue Growth | 456.6% |
| Gross Profit TTM | 8.05M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | -19.25M |
| Earnings Per Share TTM | -0.16 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | 7.288M |
| Cash Financing TTM | 17.04M |
| Cash Operations TTM | -18.81M |
| Capital Expenditures | 0.772M |
Share Statistics
| Shares Outstanding | 121.57M |
Balance Sheet
| Cash and ST Investments | 20.72M |
| Total Assets | 68.64M |
| Liabilities | 14.31M |
| Book Value | 54.32M |
| Book Value per Share | 0.4469 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.40M |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these NVAX related companies
NVAX News
NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
May 09, 8:04AM Benzinga
May 09, 8:04AM Benzinga
$ZGNX and $GERN becoming even more interesting now $NVAX not so bad today
about 22 days ago by micheleciani
about 22 days ago by micheleciani
Market Wrap Video + Additions to Watch List http://stks.co/3iY4 including: $CAR $CPTS $GWR $NVAX $PBY $PPR
about 23 days ago by StockTiger
about 23 days ago by StockTiger
$NVAX http://stks.co/3iCA for a move to 200-day ok % gain if so -n Over $1.44 to 200-day
about 23 days ago by StockTiger
about 23 days ago by StockTiger
@Bleedblue i own both lol and $GALE is making me sad but $NVAX is making me happy
about 23 days ago by MisterDevin
about 23 days ago by MisterDevin
Listen to $NVAX Q1 2012 earnings call - live at 10:00 AM, ondemand after - http://stks.co/3flk
about 27 days ago by earningscast
about 27 days ago by earningscast
$NVAX Reports First Quarter 2012 Financial Results http://stks.co/3fh4 Good
about 27 days ago by micheleciani
about 27 days ago by micheleciani
Stock on our radar $ZGNX and $NVAX both more than +10% in the last few days
about 28 days ago by micheleciani
about 28 days ago by micheleciani
NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
May 02, 8:08AM Benzinga
May 02, 8:08AM Benzinga
Novavax (NVAX) Commences Enrollment in A/H5N1 Vaccine Candidate Phase I
May 02, 8:03AM Street Insider
May 02, 8:03AM Street Insider
@JVerns Yea. $NVAX not bad, a lot of volume, been holding that for a while. $GALE has huge upside, long wait though, I'll just cont. to add
about 30 days ago by MisterDevin
about 30 days ago by MisterDevin
@MisterDevin In the same boat. $NVAX could get even more interesting tomorrow
about 30 days ago by JVerns
about 30 days ago by JVerns
NOVAVAX to Present Results From Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections
Mar 22, 9:52AM GlobeNewswire
Mar 22, 9:52AM GlobeNewswire
NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel
Mar 08, 9:00AM GlobeNewswire
Mar 08, 9:00AM GlobeNewswire
Novavax (NVAX) Commences Enrollment in Quadrivalent Seasonal VLP Phase II
Mar 01, 4:34PM Street Insider
Mar 01, 4:34PM Street Insider
NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012
Feb 24, 8:00AM GlobeNewswire
Feb 24, 8:00AM GlobeNewswire
Novavax (NVAX) India JV Makes Significant Vaccine-Development Program Progress
Jan 03, 8:17AM Street Insider
Jan 03, 8:17AM Street Insider
NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals
Jan 03, 8:06AM Benzinga
Jan 03, 8:06AM Benzinga
NOVAVAX to Present at 23rd Annual Piper Jaffray Health Care Conference
Nov 28, 12:17PM GlobeNewswire
Nov 28, 12:17PM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NVAX | 1.235 | -0.04 | -3.52% | 155.61M |
| NPK | 66.07 | -0.36 | -0.54% | 457.04M |
| NPF | 15.05 | -0.01 | -0.07% | |
| NPD | 2.62 | -0.17 | -6.09% | 287.73M |
| NPBC | 8.80 | -0.14 | -1.57% | 1.361B |
| NHC | 43.24 | -0.25 | -0.57% | 602.77M |
| NGZ | 12.75 | +0.09 | +0.71% | |
| NGX | 15.31 | -0.03 | -0.20% | |
| NGT | 21.35 | -0.15 | -0.70% | 125.96M |
| NGSX | 0.35 | -0.02 | -5.41% | 11.07M |
